OC.04.2 PERSONALIZED DOSIMETRY STRONGLY AFFECT RESPONSE TO TARE AND SURVIVAL IN PATIENTS WITH INTERMEDIATE AND ADVANCED HCC. (September 2021) - Martelletti, C.; Ricotti, A.; Berchialla, P.; Marengo, A.; Morello, E.; Richetta, E.; Rocca, R.; Tabone, M.